FDA Office of Inspections & Investigations Issues Warning Letter to Shang Hao Jia
July 22, 2026
July 22, 2026
WASHINGTON, July 22 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Shang Hao Jia Inc. from its Office of Inspections and Investigations:
* * *
Recipient: Daniel Dinghua Chen, Chief Executive Officer, Shang Hao Jia, Inc., 2311 Merced Ave, South El Monte, CA 91801, United States
Issuing Office: Office of Inspections and Investigations, United States
WARNING LETTER
* * *
Recipient: Daniel Dinghua Chen, Chief Executive Officer, Shang Hao Jia, Inc., 2311 Merced Ave, South El Monte, CA 91801, United States
Issuing Office: Office of Inspections and Investigations, United States
WARNING LETTER
